Drug–gene interactions - Open Access .click

Results 241 to 250 of about 7,431,159 (264)

Some of the next articles are maybe not open access.

Effect of Pharmacogenomic Testing for Drug–Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial

, 2023
Pharmacogenomic testing may provide some short-term benefits in antidepressant selection, leading to a higher remission rate at 12 weeks. The long-term benefits of pharmacogenomic testing are less clear.

semanticscholar +1 more source

Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions

Drug metabolism reviews (Softcover ed.)
This review explores genetic contributors to drug interactions, known as drug-gene and drug-drug-gene interactions (DGI and DDGI, respectively). This article is part of a mini-review issue led by the International Society for the Study of Xenobiotics ...
Laura E Russell +8 more
semanticscholar +1 more source

Severe CNS depression with duloxetine, ciprofloxacin and CYP2D6 deficiency—role and recognition of drug-drug-gene interactions

European Journal of Clinical Pharmacology, 2022
M. Hoffmann, S. Russmann, D. Niedrig
semanticscholar +1 more source

Aptamer–Protein Interactions: From Regulation to Biomolecular Detection

Chemical Reviews, 2023
Jie Tan, Quan Yuan, Weihong Tan
exaly

Probing and Manipulating Noncovalent Interactions in Functional Polymeric Systems

Chemical Reviews, 2022
Hongbo Zeng, Hao Zhang, Jingsi Chen
exaly

Text Mining Protocol to Retrieve Significant Drug-Gene Interactions from PubMed Abstracts.